Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study

Summary Background Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one dose of inactivated poliovirus vaccine (IPV) in routine immunisation programmes to eliminate vaccine-associated...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet infectious diseases 2015-11, Vol.15 (11), p.1273-1282
Hauptverfasser:	O'Ryan, Miguel, Prof, Bandyopadhyay, Ananda S, MBBS, Villena, Rodolfo, MD, Espinoza, Mónica, RN, Novoa, José, MD, Weldon, William C, PhD, Oberste, M Steven, PhD, Self, Steve, Prof, Borate, Bhavesh R, MBBS, Asturias, Edwin J, MD, Clemens, Ralf, MD, Orenstein, Walter, Prof, Jimeno, José, MD, Rüttimann, Ricardo, MD, Costa Clemens, Sue Ann, Prof
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Viral - blood Chile Feces - virology Female Healthy Volunteers Humans Immunization Immunization Schedule Immunogenicity Infant Infants Infectious Disease Infectious diseases Male Poliomyelitis Poliomyelitis - prevention & control Poliovirus Poliovirus Vaccine, Inactivated - administration & dosage Poliovirus Vaccine, Inactivated - adverse effects Poliovirus Vaccine, Inactivated - immunology Poliovirus Vaccine, Oral - administration & dosage Poliovirus Vaccine, Oral - adverse effects Poliovirus Vaccine, Oral - immunology Studies Treatment Outcome Vaccination - methods Vaccines Virus Shedding Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!